These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4651368)

  • 41. [Prevention of thrombosis of the arteriovenous shunts used for hemodialysis].
    Mal'kov PS; Aliev RA
    Urol Nefrol (Mosk); 1974; (6):41-4. PubMed ID: 4446186
    [No Abstract]   [Full Text] [Related]  

  • 42. Prostacyclin and heparin during haemodialysis: comparative effects.
    Camici M; Evangelisti L
    Life Support Syst; 1986; 4(3):205-9. PubMed ID: 3537544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The psychologic stress of chronic renal failure and long-term hemodialysis.
    Anger D
    Nurs Clin North Am; 1975 Sep; 10(3):449-60. PubMed ID: 809760
    [No Abstract]   [Full Text] [Related]  

  • 44. [Individual dosage schedule of heparin therapy in chronic hemodialysis by analytic studies of blood coagulation].
    Gläser V; Anstadt M
    Z Urol Nephrol; 1990 Mar; 83(3):133-40. PubMed ID: 2356667
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Femorosaphenous arteriovenous shunt for hemodialysis.
    Chavez CM; Bower JD
    South Med J; 1969 Mar; 62(3):345-7. PubMed ID: 5765131
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of a sliding scale protocol for heparin on the ability to maintain whole blood activated partial thromboplastin times within a desired range in hemodialysis patients.
    Low CL; Bailie G; Morgan S; Eisele G
    Clin Nephrol; 1996 Feb; 45(2):120-4. PubMed ID: 8846524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Experience with long-term intermittent hemodialysis therapy in patients with diabetes].
    Langsch HG; Zander E
    Z Gesamte Inn Med; 1975 Jun; 30(11):79-80 contd. PubMed ID: 1199262
    [No Abstract]   [Full Text] [Related]  

  • 48. Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients.
    Poyrazoglu OK; Dogukan A; Yalniz M; Seckin D; Gunal AL
    Ren Fail; 2006; 28(8):723-7. PubMed ID: 17162433
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal hematoma in a patient undergoing hemodialysis. Complication of acquired renal cystic disease.
    Tielemans CL; Collart FE; Hooghe L; Dratwa M
    Arch Intern Med; 1983 Aug; 143(8):1623-4. PubMed ID: 6870448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The treatment of chronic renal insufficiency in the terminal stage with hemodialysis and kidney transplantation. Current treatment of chronic renal failure].
    Toussaint C
    Infirmiere; 1968 Aug; 46(4):2-4. PubMed ID: 4877462
    [No Abstract]   [Full Text] [Related]  

  • 51. Patency of arteriovenous fistula for dialysis improbe with topical spraygel heparin.
    Stuard S; Belcaro G; Dugall M; Cesarone MR; Hosoi M; Errichi BM; Ippolito E; Bavera P; Cornelli U
    Panminerva Med; 2010 Jun; 52(2 Suppl 1):33-6. PubMed ID: 20657532
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study.
    Saxena AK; Panhotra BR
    J Nephrol; 2005; 18(6):755-63. PubMed ID: 16358235
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].
    Olszewska M
    Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Serum proteins and intermittent hemodialysis in patients with chronic renal failure].
    Ozanian V; Kiriakov Z
    Khirurgiia (Sofiia); 1974; 27(2):122-5. PubMed ID: 4425142
    [No Abstract]   [Full Text] [Related]  

  • 55. Acquired renal cystic disease and neoplasia: complications of chronic hemodialysis.
    Scanlon MH; Karasick SR
    Radiology; 1983 Jun; 147(3):837-8. PubMed ID: 6844624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of heparinization methods during hemodialysis.
    Talstad I; Kjelby K
    Am J Clin Pathol; 1985 Sep; 84(3):317-22. PubMed ID: 4036860
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of heparin on the fibrinolytic system in patients with chronic renal failure treated with hemodialysis].
    Chmielewska J; Poplawski A
    Pol Arch Med Wewn; 1976 Jul; 56(7):9-15. PubMed ID: 948464
    [No Abstract]   [Full Text] [Related]  

  • 58. HEMODIALYSIS FOR CHRONIC RENAL FAILURE. I. TECHNICAL CONSIDERATIONS.
    FREEMAN RB; MAHER JF; SCHREINER GE
    Ann Intern Med; 1965 Mar; 62():519-34. PubMed ID: 14263100
    [No Abstract]   [Full Text] [Related]  

  • 59. Short and frequent dialysis versus regional heparinisation.
    Drukker W; Haagsma-Schouten WA; Alberts C
    Lancet; 1972 Jul; 2(7767):91. PubMed ID: 4113331
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of chronic kidney failure by periodic hemodialysis].
    Vantelon J; Zingraff J; Funck-Brentano JL
    Sem Ther; 1968 May; 44(5):330-1. PubMed ID: 5682124
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.